Previous Article | Next Article ![]()
Journal of Bacteriology, March 2004, p. 1381-1387, Vol. 186, No. 5
0021-9193/04/$08.00+0 DOI: 10.1128/JB.186.5.1381-1387.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Antimicrobial Research Centre, Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada L8N 3Z51
Received 20 September 2003/ Accepted 7 November 2003
|
|
|---|
|
|
|---|
Here we present the first experimental evidence that YjeQ associates with the ribosome. We report that YjeQ copurified with ribosomes from E. coli extracts. Using recombinant, purified protein, we have revealed a 160-fold stimulation of the GTPase activity of YjeQ through interaction with the 30S ribosomal subunit. Using N-terminal truncation variants, we have delineated a role for the OB-fold region of YjeQ and for amino acids 1 to 20 in the interaction with the ribosome. The work is thus consistent with the hypothesis that YjeQ has a role in ribosome function, and it provides a solid foundation for ongoing studies to further explore this theory.
|
|
|---|
Construction of overexpression clones. Previous work characterizing recombinant YjeQ protein from E. coli showed that the expressed protein lacked the first 20 amino acids (9). Full-length YjeQ [YjeQ(1-350)] was produced with Gateway Recombination technology using a TEV protease-cleavable N-terminal His6 affinity purification tag. The gene was PCR amplified from E. coli MG1655 genomic DNA by using Vent DNA polymerase (New England Biolabs, Beverly, Mass.) and primers P1 (5'-G GGG ACA AGT TTG TAC AAA AAA GCA GGC TTA GAT TAC GAT ATC CCA ACG ACC GAA AAC CTG TAT TTT CAG * GGC AGT AAA AAT AAA CTC TCC AAA GGC-3') and P2 (5'-G GGG ACC ACT TTG TAC AAG AAA GCT GGG TCT CAG TCA TCC GTA TCA GAA AAG TTT TTA CGC G-3') (the protease cleavage site is marked with an asterisk; coding sequences are underlined). Cleavage of this protein with recombinant TEV protease yielded full-length YjeQ(1-350) where the initiator Met was replaced by Gly. YjeQ(21-350) and YjeQ(21-350) S221A were constructed and purified as previously described (9). YjeQ(114-350) was PCR amplified from plasmid pLR-1 (9) with primers P3 (5'-G GGG ACA AGT TTG TAC AAA AAA GCA GGC TTA GAA GGA GAT AGA ACC ATG GAC GGC GTA AAA CCT ATT GCC GCC-3') (coding sequences are underlined) and P2. The PCR-amplified products were cloned into plasmid pDest14 (native) or pDest17 (His6 tagged) by using Invitrogen-Life Technologies' Gateway Cloning and Expression kits. All plasmid constructs were confirmed by sequencing (MOBIX; McMaster University).
Purification of YjeQ(1-350) and variants.
To purify YjeQ(1-350), 4 liters of E. coli BL21(DE3)/pDest17YjeQ-TEV was grown at 37°C to an optical density at 600 nm (OD600) of 0.3 and was induced with isopropyl-ß-D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM for 3 h at 37°C (final OD600,
1.2). Cells were harvested by centrifugation at 15,000 x g for 20 min. The cells were resuspended in buffer A (20 mM sodium phosphate [pH 7.2]-15 mM imidazole) containing 1x Complete EDTA-free protease inhibitor cocktail (Roche Diagnostics) and lysed by three consecutive passes through a French pressure cell at 20,000 lb/in2. Cell debris was pelleted by centrifugation at 40,000 x g for 1 h at 4°C. The clarified lysate was loaded onto a HiTrap metal chelation column (bed volume, 5 ml) (Amersham Biosciences) charged with 5 ml of 100 mM nickel sulfate and preequilibrated with buffer A. A linear gradient of buffer B (buffer A plus 350 mM imidazole) over 40 column volumes was used to elute the protein. His6-YjeQ(1-350) eluted between 200 and 250 mM imidazole. Fractions containing His6-YjeQ were pooled and concentrated to 2 ml by using Amicon Ultra (Fisher Scientific, Nepean, Ontario, Canada) centrifugal concentrators (molecular size cutoff, 15 kDa), and buffer was gradually changed by buffer removal and replacement with 100 mM Tris (pH 8). The His6 tag was removed by digestion with purified recombinant TEV protease under the following conditions: 260 mg of YjeQ was digested with 6.5 mg of TEV protease for 2 h at 16°C in 50 mM Tris (pH 8)-0.5 mM EDTA-100 mM NaCl-0.25 mM DTT. The proteolyzed sample was dialyzed to remove DTT and EDTA and was rechromatographed over the HiTrap metal chelation column. YjeQ(1-350) lacking the His6 tag was located in the column flowthrough and concentrated to 2 ml. The sample was dialyzed in buffer C (50 mM HEPES [pH 7.5], 1 mM DTT), loaded onto a Q Sepharose (Amersham Biosciences) anion-exchange column (2.6 by 20 cm), and eluted with a linear gradient of buffer D (buffer C plus 1 M NaCl) over 35 column volumes. Fractions containing YjeQ eluted between 300 and 350 mM NaCl and were pooled and concentrated to 1.2 ml, followed by gel filtration chromatography on a Sephacryl S-200 column (1.6 by 70 cm) preequilibrated in buffer C. Fractions containing YjeQ were pooled, concentrated, and purified further by a second anion-exchange step on a Mono Q (Amersham Biosciences) column (bed volume, 1 ml) preequilibrated in buffer C. By use of a linear gradient of buffer D, pure YjeQ(1-350) (eluting between 320 and 340 mM NaCl and judged to be >99% pure by sodium dodecyl sulfate-polyacrylamide gel electrophoresis [SDS-PAGE] and staining with Coomassie brilliant blue R250)was pooled, concentrated, dialyzed in storage buffer (50 mM HEPES [pH 7.5], 0.5 mM DTT, 50 mM NaCl, 15% [vol/vol] glycerol), and stored at -80°C.
Untagged truncation variants of YjeQ, namely, YjeQ(21-350), YjeQ(21-350) S221A, and YjeQ(114-350), were purified as described previously (9). Protein concentrations of all variants were determined by a Bradford assay (8) and verified by the method of Gill and von Hippel (10).
Rapid isolation of ribosomes from E. coli cell extracts to determine the localization of YjeQ. Crude and rapid isolation of ribosomes from E. coli cell extracts was achieved by centrifugation at 40,000 x g for 1 h. The supernatant was further clarified by ultracentrifugation at 150,000 x g for 2 h. Stringency washes, first with 0.5% Triton, then with 60 mM NH4Cl, and finally with 1 M NH4Cl, were performed for 2 h at 4°C, according to standard methods (13). Immunoblotting using SDS-15% polyacrylamide gels was performed as described in the legend to Fig. 1.
![]() View larger version (30K): [in a new window] |
FIG. 1. Colocalization of YjeQ with ribosomes from E. coli MG1655 visualized by immunoblotting. Wild-type E. coli (4 liters) was grown in LB to an OD600 of 0.8, harvested by centrifugation at 8,500 x g for 15 min, and lysed by three consecutive passes through a French pressure cell at 10,000 lb/in2. (A) The lysate was clarified by centrifugation at 40,000 x g for 1 h, and both pellet (P) and supernatant (S) fractions were kept for analysis. (B) The supernatant was further clarified by ultracentrifugation at 150,000 x g for 2 h. (C through E) Subsequent washing and pelleting steps first with 0.5% Triton (C), then with 60 mM NH4Cl (D), and finally with 1 M NH4Cl (E) were performed by standard methods (13). At each step, pellets were resuspended in volumes identical to those of the supernatants for analysis. Immunoblotting employed SDS-15% polyacrylamide gels with a rabbit polyclonal antibody specific for YjeQ(21-350) as the primary antibody and HRP-conjugated donkey anti-rabbit IgG as the secondary antibody. Blots were developed by using the Western Lightning Chemiluminescence Reagent Plus kit (Perkin-Elmer, Boston, Mass.).
|
To obtain 70S ribosomes, the ribosomal pellet was resuspended in buffer D (10 mM Tris-HCl [pH 7.5 at 4°C], 5.25 mM magnesium acetate, 60 mM NH4Cl, 0.25 mM EDTA, 3 mM 2-mercaptoethanol) and separated by centrifugation on 10-to-30% (wt/vol) linear sucrose gradients made up in buffer D. The gradients were centrifuged at 48,000 x g for 15 h. The gradients were fractionated by upward displacement using 60% (vol/vol) glycerol, and the fractions (200 µl) were analyzed by absorbance at 260 nm as well as by SDS-15% PAGE to pool the appropriate subunits or 70S ribosomes based on their protein complement. To ensure high purity of the ribosomal subunits, fractions overlapping the A260 peak absorbance for the subunits and those judged by SDS-PAGE and Coomassie brilliant blue R250 staining to be impure were eliminated as described previously (2). Fractionation of the gradients was followed by mixing of the 70S pool with an equal volume of buffer E (10 mM Tris-HCl [pH 7.5 at 4°C], 10 mM magnesium acetate, 60 mM NH4Cl, 3 mM 2-mercaptoethanol) and centrifugation at 56,000 x g for 24 h. The 70S ribosomes were resuspended in buffer E and stored at a concentration of 1,000 A260 units/ml at -80°C (1 A260 unit is equal to 23 pmol of 70S ribosomes in buffer E). The A260/A280 ratio was determined to be 1.98.
Similarly, to obtain 30 and 50S subunits, the ribosomal pellet was resuspended in buffer F (10 mM Tris-HCl [pH 7.5 at 4°C], 1.1 mM magnesium acetate, 60 mM NH4Cl, 0.1 mM EDTA, 2 mM 2-mercaptoethanol). Fifty A260 units of the subunit suspension was layered onto 10-to-30% (wt/vol) sucrose gradients made up in buffer F, followed by centrifugation at 43,000 x g for 16 h. The gradients were fractionated as described above. The individual subunit pools were recovered by pelleting at 200,000 x g for 12 h. The pellets for both 30 and 50S ribosomes were resuspended in buffer E, clarified by centrifugation at 15,000 x g for 15 min, and stored at -80°C as described above for 70S ribosomes. Quantitation of subunits was determined by absorbance at 260 nm (1 A260 unit is equivalent to 69 or 34.5 pmol of 30 or 50S ribosomes, respectively).
|
|
|---|
100 copies/cell and consequently in a substoichiometric association with ribosomes (YjeQ/ribosome ratio, 1:200) (data not shown). Production of YjeQ(1-350) and its variants. Figure 2 shows a scaled diagram and SDS-PAGE analysis of full-length YjeQ and variants that were purified for this work. We produced full-length YjeQ(1-350) and N-terminal truncation variants lacking either the first 20 amino acids [YjeQ(21-350)] or the N-terminal OB-fold region [YjeQ(114-350)]. We also prepared an S221A variant previously characterized as having a significant impairment of the chemical hydrolytic steps in catalysis with only a minor impact on steady-state turnover (9). Full-length YjeQ(1-350) was produced by engineering a TEV protease cleavable N-terminal His6 tag to prevent proteolysis of the N terminus. Overexpression and purification of untagged YjeQ(1-350) from E. coli resulted in isolation of the truncated protein YjeQ(21-350) lacking the first 20 residues, as described previously (9). All proteins were isolated to high purity (Fig. 2B), and all the truncation variants of YjeQ possessed similar steady-state GTPase activities (Table 1).
![]() View larger version (29K): [in a new window] |
FIG. 2. YjeQ variants constructed and purified in this study. (A) Scaled diagram showing the locations of motifs in YjeQ and the deletion variants constructed. (B) Five micrograms of the purified proteins was prepared by boiling in Laemmli buffer (14) containing 8% 2-mercaptoethanol prior to SDS-15% PAGE. The gels were visualized by staining with Coomassie brilliant blue R250. YjeQ variants characterized in this study are as follows: YjeQ(1-350) (39.1 kDa) (lane 1), YjeQ(21-350) (36.8 kDa) (lane 2), YjeQ(114-350) (27.9 kDa) (lane 3), and YjeQ(21-350) S221A (36.8 kDa) (lane 4).
|
|
View this table: [in a new window] |
TABLE 1. Stimulation of YjeQ GTPase activity by ribosomal subunitsa
|
![]() View larger version (39K): [in a new window] |
FIG. 3. Binding of YjeQ to 70S ribosomes and ribosomal subunits revealed by immunoblotting. Full-length YjeQ(1-350) was tested for the ability to interact with 70S ribosomes and ribosomal subunits following a 1-h incubation in 20 mM Tris-HCl (pH 7.5)-10.5 mM magnesium acetate-60 mM NH4Cl-3 mM 2-mercaptoethanol at 30°C in the presence or absence of GDP, GTP, or GMP-PNP (2 mM). Reactions consisted of YjeQ and ribosomes, each at 2 µM. Samples (50 µl) were overlaid onto 20% (wt/vol) sucrose cushions (bed volume, 150 µl) and pelleted by ultracentrifugation at 513,000 x g in a Beckman Optima Max ultracentrifuge with a TLA 120.1 rotor for 1.5, 2, or 3 h for 70, 50, or 30S subunits, respectively. The pellets were resuspended in an equivalent volume (200 µl) of assay buffer, and supernatant (S) and pellet (P) fractions were mixed with 40 µl of sixfold-concentrated SDS-polyacrylamide gel electrophoresis loading buffer and separated by SDS-15% PAGE. Western blotting used a rabbit polyclonal antibody raised against YjeQ as the primary antibody and donkey anti-rabbit IgG coupled to HRP as the secondary antibody. (A) Binding of YjeQ to the 30S ribosomal subunit. (B) Binding of YjeQ to the 50S ribosomal subunit. (C) Binding of YjeQ to 70S ribosomes.
|
To further substantiate the binding of YjeQ to ribosomal subunits, and to confirm that results obtained by the pelleting assay reflected ribosomal interaction and not simply YjeQ precipitation in the presence of ribosomes, a complementary in vitro binding experiment was devised. YjeQ was incubated with GMP-PNP and 70S ribosomes under conditions (lower magnesium acetate concentration, 1.1 instead of 10.5 mM) that result in dissociation of 70S ribosomes to 50 and 30S ribosomal subunits (16). The sample was subsequently separated on a 10-to-30% sucrose gradient instead of being pelleted through sucrose cushions. In this gradient system, all of the YjeQ was found to comigrate with the separated ribosomal subunits, with the majority (more than 75%) comigrating with the 30S material (Fig. 4).
![]() View larger version (31K): [in a new window] |
FIG. 4. YjeQ binding to both the 30 and 50S ribosomal subunits in the presence of saturating levels of GMP-PNP (2 mM) analyzed by 10-to-30% (wt/vol) sucrose gradient ultracentrifugation. The reaction mixture consisted of 70S ribosomes (8 A260 units) purified by sucrose gradient ultracentrifugation (as described in Materials and Methods) and YjeQ, each at 3.7 µM. The sample (50 µl) was overlaid onto a 5-ml 10-to-30% (wt/vol) sucrose gradient and separated by ultracentrifugation at 43,000 x g in a Beckman Optima Max ultracentrifuge with an MLS 50 rotor for 16 h. (A) The gradient was fractionated as described in Materials and Methods, and fractions were analyzed by absorbance at 260 nm. (B) Selected fractions were separated by SDS-15% PAGE and analyzed by immunoblotting for YjeQ (as described in the legend to Fig. 3).
|
![]() View larger version (48K): [in a new window] |
FIG. 5. Salt stringency of the interaction of YjeQ(1-350) with the 30S ribosomal subunit. Immunoblotting of SDS-15% polyacrylamide gels separating pellet (P) and supernatant (S) fractions from the ribosomal pelleting assay (described in the legend to Fig. 3) was performed with increasing salt concentrations (KCl and NH4Cl) and with saturating (2 mM) levels of GMP-PNP or GDP as indicated.
|
![]() View larger version (16K): [in a new window] |
FIG. 6. Maximal stimulation of YjeQ GTPase at 1:1 stoichiometry with ribosomes. The GTPase activitiesof YjeQ and its variants were assessed by monitoring the steady-state release of phosphate from the enzyme by using the Malachite green-ammonium molybdate colorimetric assay described previously (9). All reactions were carried out at 30°C for 1 h, and reaction mixtures contained 200 nM YjeQ and saturating (2.5 mM) levels of GTP. The concentration of 30S ribosomes was varied from 3 to 800 nM. Sample data points are averages of duplicate reactions. The data were fit to a sigmoidal four-parameter equation by using SigmaPlot (version 8.0) to generate the curve shown.
|
![]() View larger version (63K): [in a new window] |
FIG. 7. Ribosomal association by YjeQ N-terminal variants. The abilities of the YjeQ N-terminal deletion variants to bind various forms of the ribosome were assayed by a ribosomal pelleting assay (described in the legend to Fig. 3). Reaction components (50 µl) were separated following a 1-h incubation at 30°C of 100 pmol of YjeQ variant and 100 pmol of ribosome in 20 mM Tris-HCl (pH 7.5)-10.5 mM magnesium acetate-60 mM NH4Cl-3 mM 2-mercaptoethanol containing 2 mM GMP-PNP. Identical binding behavior was observed when assays contained 2 mM GDP instead of GMP-PNP (data not shown). The samples were overlaid onto 20% (wt/vol) sucrose cushions (bed volume, 150 µl) and pelleted by ultracentrifugation. The pellets (P) were resuspended in a volume (200 µl) equivalent to that of supernatants (S), and both fractions were separated by SDS-15% PAGE followed by immunoblot analysis (described in the legend to Fig. 3).
|
Taken together, the effects on ribosome binding and GTPase stimulation observed with the N-terminal truncation variants suggest that the OB-fold is critical for ribosome association and associated GTPase stimulation, while the N-terminal sequence (residues 1 to 20) of YjeQ appears to be essential in imparting GMP-PNP-dependent binding affinity for the 30S ribosomal subunit.
|
|
|---|
Our work began with the routine isolation of ribosomes from wild-type E. coli. To our surprise, isolation of 70S ribosomes from E. coli and Western blotting with anti-YjeQ antibodies revealed that nearly all of the YjeQ in the cell was associated with ribosomes. Indeed, the interaction was stable to wash conditions that are typically used to remove translation factors from ribosome preparations (13). Quantitative Western blotting put the copy number of YjeQ at about 100 copies per cell, in a stoichiometry of about 1 for every 200 ribosomes, consistent with the fact that this protein has not been reported in ribosome preparations previously. In speculating on a role for this protein in ribosome function, the low copy number of the protein is noteworthy. The celebrated translational GTPases, EF-Tu, EF-G, and IF2, for example, are abundant and in near-stoichoimetry with ribosomes. Elongation factor P, on the other hand, has a relatively low copy number (EF-P/ribosome ratio, 1:30) (1) and functions in stimulating the peptidyltransferase to enhance peptide bond formation only in certain dipeptides (2). It is conceivable that YjeQ also has a critical but narrow role in a subset of translating ribosomes.
Some technical hurdles are noteworthy in the work presented here. Meticulous sucrose gradient density sedimentation procedures (16) were required to prepare highly purified ribosomes and subunits depleted of YjeQ. That material was critical to our examinations of the YjeQ-ribosome interaction in vitro by use of a ribosome pelleting assay. We also elected to troubleshoot the purification of full-length recombinant YjeQ for these experiments. It was noted previously that an N-terminal truncation variant [YjeQ(21-350)] was consistently generated upon overexpression and purification of the untagged protein (9). Here, full-length YjeQ(1-350) was produced by engineering a TEV protease cleavage site to remove an N-terminal polyhistidine tag from affinity-purified YjeQ protein. Apparently, the N-terminal tag protected YjeQ from the proteolysis that beset the native protein upon overexpression.
While YjeQ bound to all forms of the ribosome in our pelleting assay, the extent of binding, judged by the fraction of YjeQ that pelleted with a stoichiometric amount of ribosomes, varied and was the highest with the 30S ribosomal subunit, where about one-half of the YjeQ protein copelleted. Addition of GDP or GTP to the pelleting assay had no impact on the extent of binding, while the nonhydrolyzable GTP analog GMP-PNP resulted in complete copelleting of full-length YjeQ(1-350) with the ribosomal subunit. The identical outcome with GTP, GDP, and no added nucleotide is consistent with the fact that YjeQ is purified in a form bound by 0.6 equivalent of GDP and rapidly hydrolyzes GTP to GDP with a rate constant of 100 s-1 (9). The fact that the GMP-PNP-bound form of YjeQ had a higher affinity for the 30S subunit than the GDP-bound form was also evident in the stringencies of the respective interactions to increasing salt concentrations.
We speculate that we have probed, in these experiments, a physiologically relevant modulation of the 30S subunit binding activity of YjeQ in its GTP- and GDP-bound states, where the GTP analog GMP-PNP facilitates the production of a static mimic of the GTP-bound form. Such modulations are paradigmatic of signal and energy transducing G-proteins and are frequently associated with an impact on GTPase function. Thus, it follows in this work that we have also noted a significant stimulation of the steady-state GTPase activity of YjeQ by the ribosome, in particular by the 30S subunit. Also remarkable is the fact that maximum stimulation of GTPase activity occurs at a 1:1 stoichiometry of YjeQ with the ribosome. This implies that despite the low copy number of YjeQ, it is capable of a functionally significant and stoichiometric interaction with the 30S subunit.
Low intrinsic GTPase activity is not uncommon among prokaryotic translational GTPases, including EF-Tu and EF-G, which require interaction with the ribosome for maximal activity (6, 7). Interestingly, Era, another prokaryotic GTPase possessing low intrinsic activity, is stimulated by 16S rRNA and has recently been discovered to be a factor involved in the maturation of 16S rRNA (12). Full-length YjeQ's steady-state GTPase activity of 3.1 h-1 is comparable to intrinsic GTPase levels observed with EF-Tu (1.8 h-1) (15, 17). Stimulation of EF-Tu by unprogrammed ribosomes (lacking an mRNA template and associated translation factors) is about to 2- to 20-fold, while the binding of EF-Tu to programmed ribosomes results in 100,000-fold stimulation of the GTPase (to 500 s-1). Thus, the 160-fold stimulation seen here with YjeQ and unprogrammed ribosomes has a precedent. In the case of YjeQ, the pre-steady-state kinetic analysis described a rapid GTP hydrolysis step (100 s-1) followed by a much slower steady-state turnover, apparently limited by-product release (9). It seems likely that the interaction of YjeQ with the ribosome impacts primarily on product release kinetics. We will test this hypothesis in due course.
The ribosome binding experiments performed with the N-terminal truncation variants of recombinant YjeQ, presented here, have revealed the importance of the first 20 amino acids and the OB-fold for YjeQ function on the ribosome. Typically composed of a five-stranded closed ß-barrel structure and often capped by an alpha helix, OB-folds form a binding surface employed for binding oligosaccharides, proteins, and most often oligonucleotides (3). We found low but significant sequence similarity between the OB-fold in YjeQ and its orthologs and the OB-fold of the protein translation factor eIF-1A (9). Truncation of the OB-fold in the YjeQ(114-350) variant abolished binding and GTPase stimulation by the ribosome or its individual subunits. Truncation of the first 20 amino acids in YjeQ(21-350), on the other hand, showed little effect on ribosome binding or on ribosome stimulation of the GTPase activity of YjeQ. This variant exhibited behavior comparable to that of the full-length enzyme, except that its 30S binding activity was no longer modulated by the nonhydrolyzable GTP analog GMP-PNP. Given the critical role of the N-terminal 20 amino acids in the latter phenomenon, it is worth emphasizing our previous finding that this peptide is proteolytically sensitive to removal and is absent when the untagged protein is overexpressed and purified from E. coli (9). Thus, its role is likely critical to a fully functional YjeQ protein.
Information gathered in this study provides further support for the hypothesis that the YjeQ protein from E. coli and its orthologs are bacteria-specific factors with a role in ribosome function. We have concentrated in this work on the interaction of YjeQ with the ribosome and the impact of that interaction on YjeQ function. Work to address the impact of YjeQ on the function of the ribosome is ongoing.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»